Selected article for: "acute hospitalization and lupus anticoagulant"
Author: Kanso, Mohamad; Cardi, Thomas; Marzak, Halim; Schatz, Alexandre; Faucher, Loïc; Grunebaum, Lélia; Morel, Olivier; Jesel, Laurence
Title: Delayed pulmonary embolism after COVID-19 pneumonia: a case report
  • Cord-id: z67n67na
  • Document date: 2020_11_24
    • ID: z67n67na
    Snippet: BACKGROUND : Since the onset of the COVID-19 pandemic, several cardiovascular manifestations have been described. Among them, venous thromboembolism (VTE) seems to be one of the most frequent, particularly in intensive care unit patients. We report two cases of COVID-19 patients developing acute pulmonary embolism (PE) after discharge from a first hospitalization for pneumonia of moderate severity. CASE SUMMARY : Two patients with positive RT-PCR test were initially hospitalized for non-severe C
    Document: BACKGROUND : Since the onset of the COVID-19 pandemic, several cardiovascular manifestations have been described. Among them, venous thromboembolism (VTE) seems to be one of the most frequent, particularly in intensive care unit patients. We report two cases of COVID-19 patients developing acute pulmonary embolism (PE) after discharge from a first hospitalization for pneumonia of moderate severity. CASE SUMMARY : Two patients with positive RT-PCR test were initially hospitalized for non-severe COVID-19. Both received standard thromboprophylaxis during the index hospitalization and had no strong predisposing risk factors for VTE. Few days after discharge, they were both readmitted for worsening dyspnoea due to PE. One patient was positive for lupus anticoagulant. DISCUSSION : Worsening respiratory status in COVID-19 patients must encourage physicians to search for PE since SARS-CoV-2 infection may act as a precipitant risk factor for VTE. Patients may thus require more aggressive and longer thromboprophylaxis after COVID-19 related hospitalization.

    Search related documents:
    Co phrase search for related documents
    • acute pulmonary embolism and low molecular lmwh weight heparin: 1
    • acute respiratory distress syndrome and admission scan: 1, 2
    • acute respiratory distress syndrome and lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory distress syndrome and local presentation: 1
    • acute respiratory distress syndrome and long aggressive: 1
    • acute respiratory distress syndrome and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory distress syndrome and low molecular lmwh weight heparin treatment: 1, 2, 3
    • acute respiratory distress syndrome and lung auscultation: 1, 2, 3, 4
    • acute viral infection and lung auscultation: 1
    • lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh weight heparin and low molecular lmwh weight heparin treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20